Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 95 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | AIP CL E G H | 9049 | 358 | ORPHA:2965 | Prolactinoma | | | | 95 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | ARMC5 CL E G H | 79798 | 25781 | OMIM:615954 | ACTH-independent macronodular adrenal hyperplasia 2 | | | | 7 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | ATRX CL E G H | 546 | 886 | ORPHA:100075 | Neuroendocrine tumor of stomach | | | | 169 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | CDH23 CL E G H | 64072 | 13733 | ORPHA:2965 | Prolactinoma | | | | 636 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | CDH23 CL E G H | 64072 | 13733 | ORPHA:91347 | TSH-secreting pituitary adenoma | | | | 636 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | | | | 31 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | | | | 31 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | CYP11B1 CL E G H | 1584 | 2591 | ORPHA:90795 | Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency | | | | 112 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | DAXX CL E G H | 1616 | 2681 | ORPHA:100075 | Neuroendocrine tumor of stomach | | | | | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | FOXA2 CL E G H | 3170 | 5022 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 173 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 21 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | LHX4 CL E G H | 89884 | 21734 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 43 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040281 - Very frequent | | | 94 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | MC2R CL E G H | 4158 | 6930 | OMIM:202200 | Glucocorticoid deficiency 1 | | | | 94 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | MEN1 CL E G H | 4221 | 7010 | ORPHA:2965 | Prolactinoma | | | | 462 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040281 - Very frequent | | | 26 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | MRAP CL E G H | 56246 | 1304 | OMIM:607398 | Glucocorticoid deficiency 2 | | | | 26 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | | | | 11 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040281 - Very frequent | | | 13 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:786 | Generalized glucocorticoid resistance syndrome | | | | 79 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | OTX2 CL E G H | 5015 | 8522 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 41 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | OTX2 CL E G H | 5015 | 8522 | OMIM:613986 | Pituitary hormone deficiency, combined, 6 | | | | 41 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | | | | 13 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | POR CL E G H | 5447 | 9208 | OMIM:201750 | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | | | | 76 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | | | | 76 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | POR CL E G H | 5447 | 9208 | OMIM:613571 | Disordered steroidogenesis due to cytochrome P450 oxidoreductase | | | | 76 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 36 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | | | | 134 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PROP1 CL E G H | 5626 | 9455 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | | | | 54 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | PROP1 CL E G H | 5626 | 9455 | ORPHA:90695 | Non-acquired panhypopituitarism | | | | 54 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | SOX3 CL E G H | 6658 | 11199 | ORPHA:90695 | Non-acquired panhypopituitarism | | | | 24 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040281 - Very frequent | | | 45 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040281 - Very frequent | | | 85 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011043 | HP:0011043 | Abnormal circulating adrenocorticotropin concentration | 0 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 7 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 95 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | AIP CL E G H | 9049 | 358 | ORPHA:2965 | Prolactinoma | HP:0040282 - Frequent | | | 95 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 54 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | ARMC5 CL E G H | 79798 | 25781 | OMIM:615954 | ACTH-independent macronodular adrenal hyperplasia 2 | | | | 7 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | ATRX CL E G H | 546 | 886 | ORPHA:100075 | Neuroendocrine tumor of stomach | HP:0040284 - Very rare | | | 169 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 184 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:2965 | Prolactinoma | HP:0040282 - Frequent | | | 636 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:91347 | TSH-secreting pituitary adenoma | HP:0040282 - Frequent | | | 636 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | CYP11B1 CL E G H | 1584 | 2591 | ORPHA:90795 | Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency | HP:0040282 - Frequent | | | 112 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | DAXX CL E G H | 1616 | 2681 | ORPHA:100075 | Neuroendocrine tumor of stomach | HP:0040284 - Very rare | | | | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | FOXA2 CL E G H | 3170 | 5022 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | HP:0040282 - Frequent | | | | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | HP:0040282 - Frequent | | | 173 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | . | | | 101 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | HESX1 CL E G H | 8820 | 4877 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | HP:0040282 - Frequent | | | 21 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 21 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 51 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | LHX4 CL E G H | 89884 | 21734 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | HP:0040282 - Frequent | | | 43 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 43 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | MC2R CL E G H | 4158 | 6930 | OMIM:202200 | Glucocorticoid deficiency 1 | . | | | 94 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:2965 | Prolactinoma | HP:0040282 - Frequent | | | 462 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | MRAP CL E G H | 56246 | 1304 | OMIM:607398 | Glucocorticoid deficiency 2 | . | | | 26 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 220 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | HP:0040281 - Very frequent | | | 11 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:786 | Generalized glucocorticoid resistance syndrome | HP:0040281 - Very frequent | | | 79 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | OTX2 CL E G H | 5015 | 8522 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | HP:0040282 - Frequent | | | 41 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | OTX2 CL E G H | 5015 | 8522 | OMIM:613986 | Pituitary hormone deficiency, combined, 6 | | | | 41 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | . | | | 13 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 9 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 162 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | POR CL E G H | 5447 | 9208 | OMIM:201750 | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | . | | | 76 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | HP:0040282 - Frequent | | | 76 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | POR CL E G H | 5447 | 9208 | OMIM:613571 | Disordered steroidogenesis due to cytochrome P450 oxidoreductase | . | | | 76 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | HP:0040282 - Frequent | | | 36 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 36 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | . | | | 134 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PROP1 CL E G H | 5626 | 9455 | ORPHA:95494 | Combined pituitary hormone deficiencies, genetic forms | HP:0040282 - Frequent | | | 54 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 54 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | PROP1 CL E G H | 5626 | 9455 | ORPHA:90695 | Non-acquired panhypopituitarism | HP:0040282 - Frequent | | | 54 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 87 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 47 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 22 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | SOX3 CL E G H | 6658 | 11199 | ORPHA:90695 | Non-acquired panhypopituitarism | HP:0040282 - Frequent | | | 24 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 124 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 238 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011043 | HP:0002920 | Decreased circulating ACTH level | 1 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011043 | HP:0003154 | Increased circulating ACTH level | 1 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 7 | | |